Brief: Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B Regimen for Adults on Hemodialysis in the U.S.

Dynavax Technologies

14/05/2024 13:53

May 14 (Reuters) - Dynavax Technologies Corp  DVAX.O :
    * DYNAVAX PROVIDES REGULATORY UPDATE ON SBLA FOR FOUR-DOSE
HEPLISAV-B® REGIMEN FOR ADULTS ON HEMODIALYSIS IN THE U.S.

Source text for Eikon:  ID:nPn584djDa 
Further company coverage:  DVAX.O 

 ((Reuters.Briefs@thomsonreuters.com;))